MAQI2 Anticoagulation Toolkit
Published by:
The University of Michigan
Description
This mobile app provides healthcare practitioners with an up-to-date, easy-to-use resource for managing anticoagulation patients more safely and effectively. The content was developed by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a Blue Cross Blue Shield/Blue Care Network of Michigan sponsored consortium of anticoagulation clinics and experts from across the state of Michigan, and is based on the latest guidelines and research.
Hide
Show More...
Screenshots
MAQI2 Anticoagulation Toolkit FAQ
-
Is MAQI2 Anticoagulation Toolkit free?
Yes, MAQI2 Anticoagulation Toolkit is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is MAQI2 Anticoagulation Toolkit legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does MAQI2 Anticoagulation Toolkit cost?
MAQI2 Anticoagulation Toolkit is free.
-
What is MAQI2 Anticoagulation Toolkit revenue?
To get estimated revenue of MAQI2 Anticoagulation Toolkit app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in United Kingdom yet.
Ratings History
MAQI2 Anticoagulation Toolkit Reviews
No Reviews in United Kingdom
App doesn't have any reviews in United Kingdom yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
MAQI2 Anticoagulation Toolkit Installs
Last 30 days
MAQI2 Anticoagulation Toolkit Revenue
Last 30 daysMAQI2 Anticoagulation Toolkit Revenue and Downloads
Gain valuable insights into MAQI2 Anticoagulation Toolkit performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- The University of Michigan
- Languages
- English
- Recent release
- 1.44 (3 weeks ago )
- Released on
- Apr 16, 2015 (9 years ago )
- Also available in
- United States , Argentina , Italy , Philippines , South Africa , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Lithuania , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Vietnam , Pakistan , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United Arab Emirates , Uzbekistan , Dominican Republic , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , Denmark , India , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Croatia , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.